ONHS Report: HT942526SCIRPCTA

DoW Spinal Cord Injury, Clinical Trial Award

Solicitation ID: HT942526SCIRPCTA

Agency: DHA

Type: Grant

Deadline: 2026-11-12T00:00:00 ET

Eligibility: Yes (Unrestricted)

Funding: Approximately $9.76M total to fund 2 awards. Individual awards are capped at $4.8M for a Single PI or $4.96M for the Early-Career Partnership Option.

Doc Type: BAA

Clearance: No

Program Manager: N/A

Last Updated: 2026-08-19 14:59

Analyzed File: HT942526SCIRPCTA_GG.pdf

Eligibility Reasoning

Extramural and intramural U.S. Department of War (DOW) organizations are eligible to apply, including foreign and domestic organizations, for-profit and nonprofit organizations, and public or private entities. ... Applications from investigators within the DOW and applications involving multidisciplinary collaborations among academia, industry, the DOW, the U.S. Department of Veterans Affairs (VA) and other federal government agencies are highly encouraged.

Note: This is an AI-generated summary...

Summary

The Fiscal Year 2026 (FY26) Spinal Cord Injury Research Program (SCIRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials to significantly impact the treatment or management of spinal cord injury (SCI). With approximately $9.76M allocated to fund about two awards, the funding has a total cost cap of $4.8M for single-PI projects or $4.96M for an Early-Career Partnership Option, over a maximum 4-year performance period. This funding opportunity is strictly for clinical trials, ranging from small proof-of-concept to large-scale studies, and does not support preclinical research. Distinctive features include the Early-Career Partnership Option allowing for two PIs (one must be early-career), and a mandatory requirement for all applicants to name at least two SCI community partners for consultation. Proposed research must address one of four program priority areas: Acute Injury Intervention, Secondary Health Effects, Psychosocial Well-Being, or Rehabilitation and Regeneration. For studies involving investigational products, an IND or IDE application must be submitted to the relevant regulatory agency prior to the grant application deadline.

Overall Technical Areas

Spinal Cord Injury ResearchClinical Trial DesignPharmacologic InterventionsMedical Device DevelopmentRehabilitation TherapiesRegenerative MedicineNeuroplasticity InterventionsAcute Injury InterventionsSecondary Health Effects ManagementPsychosocial Intervention ResearchBiostatistics and Data AnalysisDecentralized Clinical TrialsCommunity-Based Participatory ResearchClinical Outcome Assessment

Probable LBNL Areas

N/A

Focus Areas

Example Priorities:

Develop and/or test interventions, e.g., surgical, device, pharmacologic, that protect spinal cord tissue from further damage shortly after injury and can be administered on a timeline suitable for acute trauma care in both battlefield and civilian settings.
Adoption of management/stabilization practices into the standard of care for acute spinal cord injury, leading to meaningfully improved outcomes within the prehospital, hospital or deployed environments.

Specific Technical Skills:

Acute Trauma CareSurgical InterventionsPharmacologic DevelopmentMedical Device DevelopmentNeuroprotectionBattlefield MedicineEmergency MedicineCritical CareClinical Trial Design

Potential PIs for this Area:

Name	Score	Organization

Example Priorities:

Develop and/or test interventions to prevent or manage the secondary health effects of spinal cord injury that impact injury survivors throughout their lifespan.
Adoption of interventions into the standard of care that significantly reduce the burden of secondary health effects and improve the lifelong health of SCI survivors.

Specific Technical Skills:

Chronic Disease ManagementPain ManagementCardiovascular HealthRespiratory ManagementUrologyEndocrinologyEpidemiologyClinical InterventionsLongitudinal Studies

Potential PIs for this Area:

Name	Score	Organization

Example Priorities:

Develop and/or test psychosocial interventions that are specifically tailored to the unique needs of individuals with SCI, their families and/or care partners.
Adoption of interventions into the standard of care that promote psychosocial well-being for people with SCI, their families and/or care partners.

Specific Technical Skills:

Clinical PsychologyPsychiatrySocial WorkFamily TherapyCommunity-Based ResearchPatient-Reported OutcomesMental Health CounselingQualitative ResearchIntervention Development

Potential PIs for this Area:

Name	Score	Organization

Example Priorities:

Develop and/or test rehabilitation, regenerative or neuroplastic interventions for individuals with spinal cord injury that can be implemented at any stage of life post-injury.
Adoption of validated rehabilitation and regenerative therapies into the standard of care that meaningfully improve function, independence and quality of life after SCI.

Specific Technical Skills:

Rehabilitation MedicineRegenerative MedicineNeuroplasticityNeurostimulationPhysical TherapyOccupational TherapyBiomedical EngineeringStem Cell TherapyFunctional Recovery Assessment

Potential PIs for this Area:

Name	Score	Organization

Potential LBNL PIs (Overall)

Note on PI Matching: These suggestions are generated through an AI-driven semantic analysis of LBNL staff profiles.

Name	Score	Organization
Peter Tennessen	0.73	PSA \| Engineering \| Mechanical Engineering · Medical Device Development
Yi-Chuan Lu	0.72	EESA \| CESD \| Earth System Sciences · Secondary Health Effects Management
Zixi Hu	0.72	CSA \| AMCR \| Mathematics · Biostatistics and Data Analysis
Stephanie Holm	0.72	ETA \| Energy Analysis \| Systems & Energy Tech Analysis · Community-Based Participatory Research
Kevin Fan	0.71	LD \| LD \| Strategic Partnerships · Neuroplasticity Interventions
Alan Meier	0.71	ETA \| Building Tech. & Urban Sys. \| Bldg Technologies Dept · Rehabilitation Therapies
Amy Kronenberg	0.71	BSA \| Biological Systems & Engineering \| Biodesign Dept · Clinical Trial Design
Grace Lau	0.71	ETA \| ESDR \| Energy Storage & Dist Dpt · Regenerative Medicine
Gerard Marriott	0.70	BSA \| Molecular Biophysics & Integrated Bioimaging \| Cellular & Tissue Image · Pharmacologic Interventions
Seth Carbon	0.70	BSA \| Env. Genomics & Sys. Biology \| BioSystems Data Science · Decentralized Clinical Trials

Fundamental Research Exemption (FRE)

In accordance with National Security Presidential Memorandum-33 and all associated laws, all fundamental research funded by the DOW must be evaluated for affiliations with foreign entities.